Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
26.27
+0.76 (2.98%)
At close: Oct 26, 2026, 4:00 PM EDT
26.51
+0.24 (0.91%)
After-hours: Oct 26, 2026, 4:37 PM EDT
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 624 employees as of December 31, 2025. The number of employees increased by 5 or 0.81% compared to the previous year. That makes Adaptive Biotechnologies the 18,352nd largest employer in the world and 2,510th in the United States.
Employees
624
Change (1Y)
5
Growth (1Y)
0.81%
Revenue / Employee
$493,720
Profits / Employee
-$102,330
Market Cap
4.19B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 624 | 5 | 0.81% |
| Dec 31, 2024 | 619 | -90 | -12.69% |
| Dec 31, 2023 | 709 | -81 | -10.25% |
| Dec 31, 2022 | 790 | -68 | -7.93% |
| Dec 31, 2021 | 858 | 236 | 37.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Qiagen | 5,700 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| GeneDx Holdings | 1,300 |
| GRAIL | 910 |
| CareDx | 765 |
| Veracyte | 755 |
ADPT News
- 12 days ago - Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026 - GlobeNewsWire
- 12 days ago - Adaptive Biotechnologies price target raised to $30 from $27 at JPMorgan - TheFly
- 13 days ago - Adaptive Biotechnologies price target raised to $32 from $28 at TD Cowen - TheFly
- 14 days ago - Adaptive Biotechnologies price target raised to $27 from $22 at Morgan Stanley - TheFly
- 25 days ago - Adaptive Biotechnologies price target raised to $32 from $25 at Guggenheim - TheFly
- 27 days ago - Adaptive Biotechnologies initiated with a Buy at Goldman Sachs - TheFly
- 4 weeks ago - Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure - GlobeNewsWire
- 4 weeks ago - Adaptive Biotechnologies price target raised to $34 from $25 at BTIG - TheFly